Cargando…

High-flow nasal oxygen in severe COVID-19 pneumonia and tocilizumab

Detalles Bibliográficos
Autores principales:	Mandal, M., Mazza, M., Esquinas, A.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077897/ https://www.ncbi.nlm.nih.gov/pubmed/35537687 http://dx.doi.org/10.1016/j.idnow.2022.04.008

Ejemplares similares

Respiratory rate index utility in high-flow nasal cannula oxygen therapy in COVID-19 pneumonia; what are the perfect boundaries?
por: Mazza, Mariano, et al.
Publicado: (2022)

High-flow nasal oxygen decrease mortality in patients with severe SARS-CoV-2 pneumonia? Issues and controversies
por: Di Costanzo, Domenica, et al.
Publicado: (2022)

High-flow nasal cannula oxygenation for awake craniotomy in patients with obesity: looking beyond oxygenation
por: Karim, Habib Md Reazaul, et al.
Publicado: (2022)

Comment on “Dynamic Assessment of the ROX Index as a Predictive Tool During High-flow Nasal Oxygen Therapy: Underpinning Facts”
por: Goswami, Aritra, et al.
Publicado: (2023)

The use of high-flow nasal oxygen in COPD patients
por: Silva Santos, Pedro, et al.
Publicado: (2016)

High-Flow Nasal Cannula Oxygen Delivery during Bronchoalveolar Lavage: A Question of Methodology Influence?
por: Singha, Subrata Kumar, et al.
Publicado: (2019)

Early Use of High Flow Nasal Cannula in Postextubation Period: Can It Reduce Reintubation Rate?
por: Mukherjee, Prosenjit, et al.
Publicado: (2023)

To: Efficacy and safety of high-flow nasal cannula oxygen therapy in moderate acute hypercapnic respiratory failure
por: Esquinas, Antonio M, et al.
Publicado: (2020)

High-flow nasal cannulas in COVID-19 pneumonia
por: González-Castro, Alejandro, et al.
Publicado: (2022)

Escalation to high‐flow nasal cannula oxygen in hematological malignancy: the right choice at the right moment?
por: Buonanno, Pasquale, et al.
Publicado: (2022)

High-flow Nasal Cannula Oxygenation Revisited in COVID-19
por: Rali, Aniket S, et al.
Publicado: (2020)

Successful high flow nasal cannula therapy for severe COVID-19 pneumonia is associated with tocilizumab use
por: Ouissa, R., et al.
Publicado: (2022)

Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
por: Zielecki, Piotr, et al.
Publicado: (2020)

To: Epistaxis as a complication of high-flow nasal cannula therapy in adults
por: Nair, Abhijit, et al.
Publicado: (2022)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Airway management: High flow nasal oxygenation
por: Kumar, Ajay, et al.
Publicado: (2016)

Severe COVID-19 Pneumonia in Elderly Patients: Success Rate of Compassioned Use of High Flow Nasal Cannula Therapy
por: Fabre, Isabelle, et al.
Publicado: (2023)

Nasal high-flow oxygen therapy in COVID-19 patients does not cause environmental surface contamination
por: Roca, O., et al.
Publicado: (2021)

Tweaking conventions: Use of high-flow nasal oxygen for intra-operative oxygenation in a parturient with severe COVID-19 acute respiratory distress syndrome
por: Ray, Ananya, et al.
Publicado: (2022)

Prehospital High-Flow Nasal Oxygen Therapy on COVID-19 Patients: An Additional Waiting Time
por: Cazes, Nicolas, et al.
Publicado: (2021)

Alveolar–arterial Oxygen Gradient in COVID-19 Pneumonia Initiated on Noninvasive Ventilation: Looking into the Mortality-prediction Ability
por: Karim, Habib Md Reazaul, et al.
Publicado: (2022)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Aomar-Millán, Ismael F., et al.
Publicado: (2022)

Postoperative high-flow nasal insufflation for obstructive sleep apnea: a potential therapeutic alternative or prudence needed?
por: Diaz-Abad, Montserrat, et al.
Publicado: (2019)

Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Fioravanti, Antonella, et al.
Publicado: (2020)

The feasibility of ROX index to predict intubation in patients initiated on high-flow oxygenation
por: Nair, Abhijit, et al.
Publicado: (2022)

Continuous positive airway pressure helmet in patients with ARDS due to COVID-19 pneumonia: Insights about a therapy-monitoring protocol
por: Mazza, Mariano, et al.
Publicado: (2022)

Wearing of medical mask over the high-flow nasal cannula for safer oxygen therapy in the COVID-19 era
por: Hamada, S., et al.
Publicado: (2021)

Statistical models to predict clinical outcomes with anakinra vs. tocilizumab treatments for severe pneumonia in COVID19 patients
por: Piconi, Stefania, et al.
Publicado: (2023)

Comment on “Humidification with High-Flow Nasal Cannula and Airway Epithelial Cells: Caution, Still Learning from an Extremely Complex Environment”
por: Esquinas, Antonio M., et al.
Publicado: (2012)

High-flow oxygen therapy in acute hypoxemic respiratory failure secondary to COVID-19 pneumonia()
por: Godoy, D.A., et al.
Publicado: (2021)

Authors’ Reply to: Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Liu, Bin, et al.
Publicado: (2020)

Atelectasis after pre-oxygenation with high-flow nasal cannula oxygen confirmed by electrical impedance tomography
por: Liang, Hansheng, et al.
Publicado: (2022)

High levels of TNFα in patients with COVID-19 refractory to tocilizumab
por: Danlos, F.X., et al.
Publicado: (2021)

Prone positioning in high-flow nasal cannula for COVID-19 patients with severe hypoxemia: a pilot study
por: Tu, Guo-Wei, et al.
Publicado: (2020)

Tocilizumab improves survival in patients with persistent hypoxia in severe COVID-19 pneumonia
por: Gokhale, Yojana, et al.
Publicado: (2020)

High Flow Nasal Cannula in Pediatric Intensive Care Unit: Still an Open Question [Letter]
por: Alhamad, Bshayer Ramadan, et al.
Publicado: (2021)

Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients
por: Despres, Cyrielle, et al.
Publicado: (2020)

Autoantibodies Neutralizing Type I INFs May Be Associated with Efficacy of Tocilizumab in COVID-19 Pneumonia
por: Chauvineau-Grenier, Angélique, et al.
Publicado: (2022)

The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure
por: Giraudo, C., et al.
Publicado: (2022)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sjgdno1c1hpgk42e06aiskts0v